Literature DB >> 10072557

Strain-dependent induction of allergic sensitization caused by peanut allergen DNA immunization in mice.

X Li1, C K Huang, B H Schofield, A W Burks, G A Bannon, K H Kim, S K Huang, H A Sampson.   

Abstract

To investigate the potential application of allergen gene immunization in the modulation of food allergy, C3H/HeSn (C3H) mice received i.m. injections of pAra h2 plasmid DNA encoding one of the major peanut allergens, Ara h2. Three weeks following pDNA immunization, serum Ara h2-specific IgG2a, IgG1, but not IgE, were increased significantly in a dose-dependent manner. IgG1 was 30-fold higher in multiply compared with singly immunized mice. Ara h2 or peanut protein injection of immunized mice induced anaphylactic reactions, which were more severe in multiply immunized mice. Heat-inactivated immune serum induced passive cutaneous anaphylaxis, suggesting that anaphylaxis in C3H mice was mediated by IgG1. IgG1 responses were also induced by intradermal injection of pAra h2, and by i.m. injection of pOMC, the plasmid DNA encoding the major egg allergen protein, ovomucoid. To elucidate whether the pDNA immunization-induced anaphylaxis was a strain-dependent phenomenon, AKR/J and BALB/c mice also received multiple i.m. pAra h2 immunizations. Injection of peanut protein into these strains at weeks 3 or 5 following immunization did not induce reactions. Although IgG2a was increased significantly from week 2 in AKR/J mice and from week 4 in BALB/c mice and remained elevated for at least 6 wk, no IgG1 or IgE was detected. These results indicate that the type of immune responses to pDNA immunization in mice is strain dependent. Consequently, models for studying human allergen gene immunization require careful selection of suitable strains. In addition, this suggests that similar interindividual variation is likely in humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072557

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  Future therapies for food allergies.

Authors:  Anna Nowak-Węgrzyn; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2011-01-31       Impact factor: 10.793

Review 2.  New perspectives for use of native and engineered recombinant food proteins in treatment of food allergy.

Authors:  Anna Nowak-Wegrzyn
Journal:  Immunol Allergy Clin North Am       Date:  2007-02       Impact factor: 3.479

Review 3.  Peptide and Recombinant Allergen Vaccines for Food Allergy.

Authors:  Quindelyn S Cook; A Wesley Burks
Journal:  Clin Rev Allergy Immunol       Date:  2018-10       Impact factor: 8.667

Review 4.  Treatments for food allergy: how close are we?

Authors:  Julie Wang; Hugh A Sampson
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

5.  A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy.

Authors:  R A Wood; S H Sicherer; A W Burks; A Grishin; A K Henning; R Lindblad; D Stablein; H A Sampson
Journal:  Allergy       Date:  2013-04-29       Impact factor: 13.146

Review 6.  Novel approaches to food allergy.

Authors:  Yao-Hsu Yang; Bor-Luen Chiang
Journal:  Clin Rev Allergy Immunol       Date:  2014-06       Impact factor: 8.667

Review 7.  Food allergies.

Authors:  Paula F G O'Leary; Fergus Shanahan
Journal:  Curr Gastroenterol Rep       Date:  2002-10

8.  Food allergy: recent advances in pathophysiology and treatment.

Authors:  Julie Wang; Hugh A Sampson
Journal:  Allergy Asthma Immunol Res       Date:  2009-09-25       Impact factor: 5.764

9.  Maternal peanut exposure during pregnancy and lactation reduces peanut allergy risk in offspring.

Authors:  Iván López-Expósito; Ying Song; Kirsi M Järvinen; Kamal Srivastava; Xiu-Min Li
Journal:  J Allergy Clin Immunol       Date:  2009-11       Impact factor: 10.793

Review 10.  Current and Emerging Therapies for IgE-Mediated Food Allergy.

Authors:  Robbie D Pesek; Stacie M Jones
Journal:  Curr Allergy Asthma Rep       Date:  2016-04       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.